Inhibition of noradrenergic and corticotrophin-releasing factor systems: Effects on enhancement of memory consolidation by unconditioned and conditioned heroin withdrawal.
Adrenocorticotropic Hormone
/ pharmacology
Analgesics, Opioid
/ pharmacology
Animals
Corticotropin-Releasing Hormone
/ pharmacology
Heroin
/ pharmacology
Male
Memory Consolidation
Naloxone
/ pharmacology
Narcotics
/ pharmacology
Norepinephrine
/ pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Corticotropin-Releasing Hormone
Substance Withdrawal Syndrome
Conditioned withdrawal
Corticotropin-releasing factor
Memory consolidation
Noradrenaline
Opioid withdrawal
Opioids
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
15 05 2022
15 05 2022
Historique:
received:
26
10
2021
revised:
21
02
2022
accepted:
24
02
2022
pubmed:
4
3
2022
medline:
15
4
2022
entrez:
3
3
2022
Statut:
ppublish
Résumé
The aim of the current study was to test the hypothesis that unconditioned and conditioned opioid withdrawal enhance memory consolidation through overlapping neural systems. The reported experiments focussed on noradrenaline (NA) and corticotrophin-releasing factor (CRF) because of their known involvement in both opioid withdrawal and memory consolidation. Male Sprague-Dawley rats were implanted with subcutaneous osmotic mini-pumps releasing 3.5 mg/kg/day heroin and received injections of 3 mg/kg naloxone (NLX) to precipitate withdrawal. NLX was preceded by 0.1-0.6 mg/kg lofexidine (LOF) (alpha-2 adrenergic agonist) or 10-20 mg/kg antalarmin (ANT) (CRF1 receptor antagonist), and all injections were administered immediately after (i.e., post-training method) the sample phase of the spontaneous object recognition memory task. The same procedure was repeated 7 days after removal of the mini-pumps. To establish conditioned withdrawal, heroin-exposed rats were confined for 2 h in a context (CS+) following injections of 3 mg/kg NLX and in another context (CS-) following vehicle injections. Seven days after removal of mini-pumps, the effects of immediate post-sample exposure to the CS+ (and CS-) preceded by 0.6 mg/kg LOF or 20 mg/kg ANT were assessed. It was found both LOF and ANT blocked the enhancement of object memory by post-sample NLX administration and by exposure to the CS+. These results suggest that pharmacological and psychological withdrawal impact memory storage by activating overlapping NA and CRF systems.
Identifiants
pubmed: 35240132
pii: S0028-3908(22)00077-6
doi: 10.1016/j.neuropharm.2022.109018
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Narcotics
0
Receptors, Corticotropin-Releasing Hormone
0
Naloxone
36B82AMQ7N
Heroin
70D95007SX
Adrenocorticotropic Hormone
9002-60-2
Corticotropin-Releasing Hormone
9015-71-8
Norepinephrine
X4W3ENH1CV
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
109018Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.